Serum apolipoprotein A1 rather than apolipoprotein B is associated with hypertension prevalence in Chinese people with coronary artery disease

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Hongli Dong ◽  
Yaju Zhang ◽  
Ping Hu ◽  
Jie Wang ◽  
Nan Lu
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Apolipoprotein B ◽  
Apolipoprotein A1 ◽  
Chinese People ◽  
Hypertension Prevalence ◽  
Artery Disease

DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients

2008 ◽  
Vol 42 (4) ◽  
pp. 164-170 ◽  
Author(s):  
N. Saha ◽  
M. C. Tong ◽  
J. S. H. Tay ◽  
K. Jeyaseelan ◽  
S. E. Humphries
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Apolipoprotein B ◽  
Dna Polymorphisms ◽  
Artery Disease ◽  
Apolipoprotein B Gene

Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease

2008 ◽  
Vol 313 (1-2) ◽  
pp. 139-146 ◽  
Author(s):  
Taranjit Singh Rai ◽  
Madhu Khullar ◽  
B. S. Sehrawat ◽  
Monica Ahuja ◽  
Praveen Kumar Sharma ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Synergistic Effect ◽  
Apolipoprotein E ◽  
Gene Polymorphisms ◽  
Apolipoprotein A1 ◽  
Artery Disease

Coronary artery disease risk predicted by plasma concentrations of high-density lipoprotein cholesterol, apolipoprotein AI, apolipoprotein B, and lipoprotein(a) in a general Chinese population

1993 ◽  
Vol 39 (2) ◽  
pp. 209-212 ◽  
Author(s):  
J H Wu ◽  
J T Kao ◽  
M S Wen ◽  
D Wu
Keyword(s):  
Risk Factors ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
High Density Lipoprotein ◽  
High Density Lipoprotein Cholesterol ◽  
Apolipoprotein B ◽  
Density Lipoprotein ◽  
Control Group ◽  
Apolipoprotein Ai ◽  
Artery Disease

Abstract We measured lipid and lipoprotein concentrations in blood samples from control subjects and patients with coronary artery disease (CAD) in Taiwan. We found significant differences (P < 0.01) in the concentrations of high-density lipoprotein cholesterol (HDLC), apolipoprotein AI (ApoAI), apolipoprotein B (ApoB), and lipoprotein(a) [Lp(a)]. Concentrations of HDLC < 350 mg/L, ApoAI < 900 mg/L, ApoB > 800 mg/L, and Lp(a) > 200 mg/L occurred, respectively, 2.8, 5.2, 1.7, and 2.3 times more frequently in the patients than in the control group. If one considers HDLC at < 350 mg/L, ApoAI at < 900 mg/L, ApoB at > 800 mg/L, and Lp(a) at > 200 mg/L as separate risk factors for CAD, the ratio of individual patients to control subjects having 4, 3, 2, 1, or 0 risk factors was [symbol: see text] 9.4, 2.1, 0.2, 0.2, respectively. Individuals displaying three or more risk factors were found 15 times more frequently in the CAD group than in the control group. These risk factors may be used clinically for the prediction and prevention of CAD in the general population.

scholarly journals Apolipoprotein B and Coronary Artery Disease in Women

1998 ◽  
Vol 18 (7) ◽  
pp. 1101-1107 ◽  
Author(s):  
H. Tineke Westerveld ◽  
Jeanine E. Roeters van Lennep ◽  
Henk W. O. Roeters van Lennep ◽  
An-Ho Liem ◽  
Job A. J. de Boo ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Apolipoprotein B ◽  
Artery Disease
Sign in / Sign up

Export Citation Format

Share Document